Ipilimumab cystic hypophysitis mimicking metastatic melanoma
Ipilimumab is an immunotherapeutic agent used in the treatment of metastatic melanoma, and is known to cause hypophysitis in some patients. Magnetic resonance imaging of ipilimumab-induced hypophysitis typically shows diffuse enlargement of the pituitary gland with variable enhancement or enlargemen...
Main Authors: | John Wallace, BS, Martin Krupa, MD, James Brennan, MD, Frank Mihlon, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-06-01
|
Series: | Radiology Case Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1930043317304818 |
Similar Items
-
Ipilimumab (Immune Checkpoint Inhibitors) Hypophysitis
by: Margot Stagnetto, et al.
Published: (2020-11-01) -
IPILIMUMAB IN THERAPY OF METASTATIC MELANOMA
by: I. V. SAMOILENKO, et al.
Published: (2016-12-01) -
Ipilimumab Pharmacotherapy in Patients with Metastatic Melanoma
by: Joanne M. Jeter, et al.
Published: (2012-07-01) -
Ipilimumab Pharmacotherapy in Patients with Metastatic Melanoma
by: Joanne M. Jeter, et al.
Published: (2012-01-01) -
Ipilimumab-Induced Neutropenia in Melanoma
by: Makiko Ban-Hoefen MD, et al.
Published: (2016-08-01)